Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Azeem

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Plos One|January 25, 2023
Farmers' beliefs and concerns about climate change, and their adaptation behavior to combat climate change in Saudi ArabiaMuhammad I Azeem, Bader Alhafi Alotaibi
Irish Medical Journal|February 25, 2025
Optimising Post-Operative Imaging in HemiarthroplastyI Azeem, C Keogh, M Umar, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 10, 2013
Has Hajj-associated Middle East Respiratory Syndrome Coronavirus transmission occurred? The case for effective post-Hajj surveillance for infectionH Rashid, M I Azeem, L Heron, et al.
The Journal of Clinical Investigation|May 2, 2024
Tregs protect against combination checkpoint blockade toxicity induced by Tph and B cell interactionsAlyssa Duffy, Maryam I Azeem, Smriti Kanangat, et al.
Vaccine|March 21, 2018
Influenza vaccination among Saudi Hajj pilgrims: Revealing the uptake and vaccination barriersMohammad Alfelali, Osamah Barasheed, Al-Mamoon Badahdah, et al.
Blood Advances|February 6, 2025
Immune-aging is linked to clinical malignancy, racial ancestry, and vaccine responses in myelomaSayalee V Potdar, Shivani Kapadia, Maryam I Azeem, et al.
Nature Cancer|August 26, 2024
Clinical response and pathway-specific correlates following TIGIT-LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trialShambavi Richard, Alexander M Lesokhin, Barry Paul, et al.
Journal of Travel Medicine|March 4, 2020
Meningococcal and pneumococcal carriage in Hajj pilgrims: findings of a randomized controlled trialAl-Mamoon Badahdah, Marwan A Bakarman, Ameneh Khatami, et al.
The Journal of Clinical Investigation|August 5, 2025
Early CD4+ T-cell proliferative burst and chronic T-cell engagement impact myeloma outcomes following T-cell engager therapyAlyssa M Duffy, Anshika Goenka, Maryam I Azeem, et al.
NPJ Vaccines|October 28, 2024
Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunityAlberto Moreno, Kelly Manning, Maryam I Azeem, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Plos One|January 25, 2023
Farmers' beliefs and concerns about climate change, and their adaptation behavior to combat climate change in Saudi ArabiaMuhammad I Azeem, Bader Alhafi Alotaibi
Irish Medical Journal|February 25, 2025
Optimising Post-Operative Imaging in HemiarthroplastyI Azeem, C Keogh, M Umar, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 10, 2013
Has Hajj-associated Middle East Respiratory Syndrome Coronavirus transmission occurred? The case for effective post-Hajj surveillance for infectionH Rashid, M I Azeem, L Heron, et al.
The Journal of Clinical Investigation|May 2, 2024
Tregs protect against combination checkpoint blockade toxicity induced by Tph and B cell interactionsAlyssa Duffy, Maryam I Azeem, Smriti Kanangat, et al.
Vaccine|March 21, 2018
Influenza vaccination among Saudi Hajj pilgrims: Revealing the uptake and vaccination barriersMohammad Alfelali, Osamah Barasheed, Al-Mamoon Badahdah, et al.
Blood Advances|February 6, 2025
Immune-aging is linked to clinical malignancy, racial ancestry, and vaccine responses in myelomaSayalee V Potdar, Shivani Kapadia, Maryam I Azeem, et al.
Nature Cancer|August 26, 2024
Clinical response and pathway-specific correlates following TIGIT-LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trialShambavi Richard, Alexander M Lesokhin, Barry Paul, et al.
Journal of Travel Medicine|March 4, 2020
Meningococcal and pneumococcal carriage in Hajj pilgrims: findings of a randomized controlled trialAl-Mamoon Badahdah, Marwan A Bakarman, Ameneh Khatami, et al.
The Journal of Clinical Investigation|August 5, 2025
Early CD4+ T-cell proliferative burst and chronic T-cell engagement impact myeloma outcomes following T-cell engager therapyAlyssa M Duffy, Anshika Goenka, Maryam I Azeem, et al.
NPJ Vaccines|October 28, 2024
Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunityAlberto Moreno, Kelly Manning, Maryam I Azeem, et al.
Pageof 2